Emery Hoos

Emery graduated with highest honors from the University of North Carolina at Chapel Hill in 2024, where she studied public health and biology. Working with Dr. Rebecca Fry, her undergraduate research focused on epigenetic differences related to endometrial cancer, specifically those underlying to molecular subtypes and survival. She utilized publicly-available data from The Cancer Genome Atlas, then moved to incorporate further data from UNC patients. Emery also worked for a summer in the lab of Dr. Robert Seder, exploring CD8+ T cell phenotype in cancer vaccines and adoptive cell therapy. 

Emery is excited to apply these previous research experiences to her work with Dr. Sri Krishna (NCI), Dr. Malcolm Sim (Oxford) and Dr. Timothy Elliott (Oxford), where she will characterize differences in avidity and affinity of neoantigen-specific T cell receptors to better understand the ideal candidates for cellular therapies in cancer.